Status:

COMPLETED

Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-naïve Adults

Lead Sponsor:

Pfizer

Conditions:

Pneumococcal Disease

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

A Phase 3, Randomized, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults

Eligibility Criteria

Inclusion

  • Male or female adults \>/= 18 years of age (from the 18th birthday) at enrollment and older.
  • Adults determined by clinical assessment, including medical history and clinical judgment, to be eligible for the study, including adults with preexisting stable disease, defined as disease not requiring significant change in therapy in the previous 6 weeks or hospitalization for worsening disease within 12 weeks before receipt of investigational product.
  • Negative urine pregnancy test at Visit1 for all subjects who are of childbearing potential.

Exclusion

  • Previous vaccination with any licensed or investigational pneumococcal vaccine, or planned receipt through study participation.
  • History of microbiologically proven invasive disease caused by S pneumoniae.
  • Serious chronic disorder including metastatic malignancy, severe chronic obstructive pulmonary disease (COPD) requiring supplemental oxygen, end-stage renal disease with or without dialysis, clinically unstable cardiac disease, or any other disorder that, in the investigator's opinion, excludes the subject from participating in the study.
  • Pregnant female subjects or breastfeeding female subjects.

Key Trial Info

Start Date :

December 12 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 16 2019

Estimated Enrollment :

3902 Patients enrolled

Trial Details

Trial ID

NCT03760146

Start Date

December 12 2018

End Date

December 16 2019

Last Update

December 2 2021

Active Locations (68)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 17 (68 locations)

1

Accel Research Sites

Birmingham, Alabama, United States, 35216

2

Coastal Clinical Research, Inc.

Mobile, Alabama, United States, 36608

3

East Valley Gastroenterology and Hepatology Associates

Chandler, Arizona, United States, 85224

4

The Pain Center of Arizona

Peoria, Arizona, United States, 85381

Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-naïve Adults | DecenTrialz